Quantessence Capital’s Verona Pharma VRNA Stock Holding History

Quantessence Capital’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-110,237	Closed	-$11.8M	–	163
2025 Q3	$11.8M	Buy	+110,237	New	+$11.5M	3.72%	2

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Quantessence Capital's VRNA Position: Q4 2025 in Review

Quantessence Capital sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 110,237 shares — an estimated $11.8M sold.

Quantessence Capital first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $11.8M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Quantessence Capital reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Quantessence Capital sold 110,237 Verona Pharma shares in Q4 2025, an estimated $11.8M.
Quantessence Capital first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Quantessence Capital's Verona Pharma position peaked at $11.8M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Quantessence Capital's 13F filing for Q4 2025, filed 17 Feb 2026.